--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Glucose Buddy Diabetes Tracker" developer_entity: "Azumio Inc." bundle_id: "com.OneAppOneCause.GlucoseBuddy" app_store_id: "294754639" google_play_id: "com.skyhealth.glucosebuddyfree" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-04-26" report_date: "2026-08-04" last_verified: "2026-08-04T00:00:00.000Z" report_version: "5.442" total_reviews: 39132 overall_rating: 3.9 sentiment: "Frustrated" sentiment_score: 25 confidence: "high" confidence_score: 0.85 top_praise_theme: "Long-term users value the comprehensive tracking of glucose, blood pressure, and weight in one location" top_complaint_theme: "Critical stability issues post-update cause the application to freeze or display a blank loading screen" review_sample_size: 509 total_review_count: 509 analyzed_review_count: 95 data_age_days: 12 momentum_velocity: "maintenance" intelligence_version: 5 nemesis: "mySugr - Diabetes Tracker Log" competitor_count: 7 tags: ["medical", "subscription", "frustrated sentiment", "mobile app", "app review", "app analysis", "individuals", "managing", "diabetes"] canonical_url: "https://marlvel.ai/apps/com-oneapponecause-glucosebuddy" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Glucose Buddy Diabetes Tracker Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 3.87 · Sentiment Frustrated - **Recent focus**: Critical stability issues post-update cause the application to freeze or display a blank loading screen (top complaint) · Long-term users value the comprehensive tracking of glucose, blood pressure, and weight in one location (top praise) > **TL;DR:** Glucose Buddy Diabetes Tracker is a medical app by Azumio Inc., rated 3.87/5 by 39.1K users, with Frustrated user sentiment (25/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Glucose Buddy Diabetes Tracker faces Frustrated user sentiment (3.87/5 from 39.1K reviews), with users reporting critical stability issues post-update cause the application to freeze or display a blank loading screen as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 3.87/5 (39.1K reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Azumio Inc. | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | High (0.85/1.0) | | **Data Age** | 12d | ## Metadata & Market Performance - **Publisher:** Azumio Inc. - **Category:** Medical - **Target Audience:** Individuals managing diabetes who require consistent blood glucose tracking, meal logging, and professional health guidance. - **Platforms:** iOS & Android - **Version Reviewed:** 5.442 - **Report Date:** 2026-08-04 - **Signal Count:** 509 reviews analyzed - **Confidence:** High (0.85/1.0) - **App Store ID (iOS):** 294754639 - **Bundle ID:** com.OneAppOneCause.GlucoseBuddy - **Google Play ID:** com.skyhealth.glucosebuddyfree - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-04 - **Short Description:** Track blood glucose, A1C, carbs, medication, exercise, and more all in one app! ## Executive Snapshot **What it is:** Glucose Buddy is a medical tracking app for diabetes management, allowing users to log blood glucose, medication, and health metrics on iOS and Android. **Why users hire it:** It serves as a centralized health record for patients who need to share long-term A1C and glucose trends with their medical providers. ## App DNA (Features & Intent) - **[Standard] Glucose and Health Metric Logging:** Manual entry for blood glucose, medication, insulin, weight, and activity levels. - **[Differentiator] Automatic A1C Calculator:** Calculates long-term A1C trends based on logged glucose data, gated behind premium. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Smart Meter Integration:** Direct sync with Agamatrix Jazz Wireless 2 meters for automated data capture. * *User Intent:* Users expect seamless access across multiple devices. ## Market Position {#market-position} Glucose Buddy holds a #51 Grossing position in the US Medical category, yet the 325-day average update cadence signals a shift into maintenance mode. This stagnation leaves the app vulnerable to high-velocity rivals that prioritize real-time data automation over manual logging. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free tier with ad support, Premium subscription starting at $19/month - **Analysis:** Freemium model gates advanced analytics and ad-free usage behind a subscription, while offering high-touch coaching services as a primary revenue driver. ## 🔴 User Sentiment (High Confidence: 95 of 509 reviews analyzed) {#user-sentiment} - **Overall Rating:** 3.87/5 - **Platform Split:** iOS 4.8/5 (24.6K ratings) | Android 2.3/5 (14.6K ratings) - **Overall Sentiment:** Frustrated ### Top Praises - **Long-term users value the comprehensive tracking of glucose, blood pressure, and weight in one location** - **Intuitive data visualization and export features help patients share health trends with their medical providers** ### Top Complaints (Impact Areas) - **Critical stability issues post-update cause the application to freeze or display a blank loading screen** ## SWOT Analysis {#swot} **Core Strengths:** - 15-year market presence builds high trust for legacy users - Consolidated dashboard reduces cognitive load for multi-metric tracking **Growth Levers:** - Native CGM integration would remove manual-entry friction - Barcode scanning improvements would increase logging accuracy for daily users ## Recent Changes (v4 → v5) {#recent-changes} Technical instability and aggressive monetization have intensified, shifting the primary stability complaint to a transitional status and adding new weaknesses regarding paywall-blocked core functionality. The app's grossing rank improved slightly to #51, but this is now viewed as a liability tied to legacy revenue models rather than product growth. **Overall trend**: Declining **Compared at**: 2026-08-04 ### High-impact changes - **[Declined] Stability Complaint Escalation** (sentiment) - **[] New Weaknesses Identified** (swot) ### Medium-impact changes - **[] Expanded Feature Gaps** (features) - **[] New Opportunity Identified** (swot) - **[] Grossing Rank Reinterpretation** (positioning) ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Glucose Buddy Diabetes Tracker vs mySugr - Diabetes Tracker Log - **[mySugr - Diabetes Tracker Log](https://marlvel.ai/apps/com-mysugr-companion-mysugr)** by mySugr GmbH: With over 134,000 reviews and a high-velocity release cadence, mySugr is the dominant direct competitor in the diabetes logging space. - **Key differences:** - Gamified logging experience provides immediate positive reinforcement for consistent blood glucose data entry - Deep integration with various continuous glucose monitors (CGM) automates data flow for power users - High-frequency release cycle of 12 updates in six months ensures rapid feature iteration and stability ### Contenders (Strong Challengers) - **[Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe)** by MediSafe Inc.: A strong contender that captures the medication adherence segment of the diabetes management workflow. - Specialized medication reminder engine with family caregiver alerts outperforms generic logging features - Drug-to-drug interaction checking provides a safety layer that standard diabetes trackers lack - **[Libre by Abbott](https://marlvel.ai/apps/com-abbott-adc-freestyle-libre-us)** by Abbott Labs: Dominates the CGM-specific niche, serving as a critical utility for users requiring real-time glucose monitoring. - Real-time glucose streaming capabilities eliminate the need for manual logging of blood sugar levels - Hardware-integrated alerts provide immediate notification of dangerous glucose fluctuations for patient safety - **[OneTouch Reveal® app](https://marlvel.ai/apps/com-lifescan-reveal)** by LifeScan, Inc.: A major contender backed by a medical device manufacturer, focusing on seamless hardware-to-app data synchronization. - Direct hardware ecosystem lock-in through proprietary blood glucose meter connectivity and data syncing - Clinical-grade reporting features designed specifically for sharing accurate data with healthcare providers ### Peers (What They Do Better) - **[Kardia](https://marlvel.ai/apps/com-alivecor-professional-aliveecg)** by AliveCor, Inc.: Adjacent chronic condition monitoring, focusing on cardiovascular health often comorbid with diabetes. - Medical-grade ECG analysis capabilities provide specialized diagnostic value beyond simple glucose tracking - Hardware-software synergy with portable ECG devices creates a distinct clinical diagnostic workflow - **[GoodRx: Prescription Savings](https://marlvel.ai/apps/com-goodrx-iphone)** by GoodRx: Adjacent medical utility that captures the financial pain point of diabetes management. - Aggressive price comparison engine for prescriptions creates a high-utility financial moat for patients - Massive user base and brand recognition as the primary tool for reducing healthcare costs ### New Kids on the Block (What's Innovative) - **[Blood Pressure Tracker •](https://marlvel.ai/apps/com-adappt-bp)** by App Sub 1 LLC: Recent updates and high activity suggest an emerging focus on comorbid condition tracking. - Minimalist, single-purpose interface design reduces friction for elderly users tracking blood pressure - Rapid release cadence indicates a focus on quick feature deployment to capture niche users ## What's New - **Latest (v5.442, 3 weeks ago):** UI redesign, performance upgrades, and bug fixes. ## App Momentum (Maintenance) {#momentum} - Ships bug fixes at ~4-month cadence. - No new feature builds in 2026. - Last major update over 100 days ago. > **Cadence:** 3 total versions · 0 majors in last 6 months · 22 days since last update · 325 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Glucose Buddy Diabetes Tracker is a medical app. With a 3.87/5 rating from 39.1K reviews, it faces significant user friction. > **Bottom Line:** Users report: The app's legacy trust is being liquidated by technical instability and aggressive monetization. Restoring stability is the only way to defend the current user base against high-velocity rivals that offer superior automated data capture. **Best for:** Individuals managing diabetes who require consistent blood glucose tracking, meal logging, and professional health guidance. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Audit launch-day stability because crashes on launch are the top-cited churn driver → restore daily active habit ### Feature Gaps vs Competitors - Real-time CGM streaming (available in Libre by Abbott, missing here) ### Outlook: Declining The diabetes management market is consolidating around automated data streaming, leaving manual-entry tools like Glucose Buddy increasingly isolated. Without a shift to real-time CGM integration, the app will continue to lose market share to hardware-integrated rivals that provide higher clinical value with lower user effort. - 🔴 The 325-day update cadence indicates a shift to maintenance mode, which prevents the app from matching the rapid feature iteration of direct rivals. - 🔴 Persistent launch-day crashes post-update erode the daily logging habit, which directly accelerates churn among the core user base. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 3.87/5 | | Total Reviews | 39.1K | | Sentiment | Frustrated (25/100) | | Confidence | High | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Glucose Buddy Diabetes Tracker** (this app) | 3.87/5 | Frustrated | Azumio Inc. | | [Libre by Abbott](https://marlvel.ai/apps/com-abbott-adc-freestyle-libre-us) | 4.6/5 | Mixed | Abbott Labs | | [GoodRx: Prescription Savings](https://marlvel.ai/apps/com-goodrx-iphone) | 4.8/5 | Thrilled | GoodRx | | [Medisafe Medication Management](https://marlvel.ai/apps/com-medisafe-medisafe) | 4.7/5 | n/a | MediSafe Inc. | | [Kardia](https://marlvel.ai/apps/com-alivecor-professional-aliveecg) | 4.8/5 | N/A | AliveCor, Inc. | | [OneTouch Reveal® app](https://marlvel.ai/apps/com-lifescan-reveal) | 4.8/5 | N/A | LifeScan, Inc. | ## Company Profile - **Developer:** Azumio Inc. - **Website:** [https://www.glucosebuddy.com](https://www.glucosebuddy.com) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/glucose-buddy-diabetes-tracker/id294754639?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.skyhealth.glucosebuddyfree&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.glucosebuddy.com) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*Libre by Abbott*](https://marlvel.ai/apps/com-abbott-adc-freestyle-libre-us) (Abbott Labs) · 4.6/5 Rating - [*GoodRx: Prescription Savings*](https://marlvel.ai/apps/com-goodrx-iphone) (GoodRx) · 4.8/5 Rating | Excellent Sentiment - [*Medisafe Medication Management*](https://marlvel.ai/apps/com-medisafe-medisafe) (MediSafe Inc.) · 4.7/5 Rating - [*Kardia*](https://marlvel.ai/apps/com-alivecor-professional-aliveecg) (AliveCor, Inc.) · 4.8/5 Rating - [*OneTouch Reveal® app*](https://marlvel.ai/apps/com-lifescan-reveal) (LifeScan, Inc.) · 4.8/5 Rating - [*Blood Pressure Tracker •*](https://marlvel.ai/apps/com-adappt-bp) (App Sub 1 LLC) · 4.7/5 Rating - [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/apps/com-mysugr-companion-mysugr) (mySugr GmbH) · 4.7/5 Rating - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.85/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 509 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 12 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-oneapponecause-glucosebuddy) Data licensed for AI Agent attribution under CC-BY-NC 4.0.